VYTORIN (Merck Sharp & Dohme Corp.)
Welcome to the PulseAid listing for the VYTORIN drug offered from Merck Sharp & Dohme Corp.. This Decreased Cholesterol Absorption [PE],Dietary Cholesterol Absorption Inhibitor [EPC],HMG-CoA Reductase Inhibitor [EPC],Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
| LABELER NAME / MANUFACTURER: | Merck Sharp & Dohme Corp. |
| NON-PROPRIETARY NAME: | ezetimibe and simvastatin |
| SUBSTANCE NAME: | EZETIMIBE; SIMVASTATIN |
| TYPE: | HUMAN PRESCRIPTION DRUG |
| PHARMA CLASS: | Decreased Cholesterol Absorption [PE],Dietary Cholesterol Absorption Inhibitor [EPC],HMG-CoA Reductase Inhibitor [EPC],Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA] |
| ROUTE: | ORAL |
| DOSAGE FORM: | TABLET |
| MARKETING CATEGORY NAME: | NDA |
| START MARKETING DATE: | 2004-07-23 |
| END MARKETING DATE: | 0000-00-00 |
VYTORIN HUMAN PRESCRIPTION DRUG Details:
| Item Description | VYTORIN from Merck Sharp & Dohme Corp. |
| LABELER NAME: | Merck Sharp & Dohme Corp. |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | 10; 20(mg/1; mg/1) |
| START MARKETING DATE: | 2004-07-23 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 66582-312_fe4838bc-c614-4555-872c-37b179d8c233 |
| PRODUCT NDC: | 66582-312 |
| APPLICATION NUMBER: | NDA021687 |
Other EZETIMIBE; SIMVASTATIN Pharmaceutical Manufacturers / Labelers:
